• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public calendar: August 29-September 2, 2011

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

August 29-September 2, 2011
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs9/1/11Silver Spring, MDRichard Pazdur, Heidi Marchand, Richard Klein, and Jeff O’Neill
Fran Visco and Dana Richter (The National Breast Cancer Coalition)National Breast Cancer Coalition’s Mission, Ending Breast Cancer Deadline 2020 
John M. Taylor, III, J.D., Counselor to the Commissioner8/31/11Silver Spring, MD Several FDA Staff Shaun Gilmore and several representatives from American Red Cross American Red Cross 
Deborah M. Autor, Esq., Deputy Commissioner for Global Regulatory Operations and Policy8/29/11-9/2/11N/AN/AN/ANo Significant Meetings 
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs8/29/11-9/2/11N/AN/AN/ANo Significant Meetings 
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products8/29/11-9/2/11N/AN/AN/ANo Significant Meetings 
Elizabeth H. Dickinson, Esq., Acting Chief Counsel8/29/11-9/2/11N/AN/AN/ANo Significant Meetings 
David Dorsey, J.D., Acting Associate Commissioner for Policy and Planning8/29/11-9/2/11N/AN/AN/ANo Significant Meetings 
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine8/29/11-9/2/11N/A N/A N/ANo Significant Meetings
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health8/29/11-9/2/11N/AN/AN/ANo Significant Meetings 
Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition8/29/11-9/2/11N/AN/AN/ANo Significant Meetings 
Caroline Lewis, Acting Deputy Commissioner for Administration8/29/11-9/2/11N/AN/AN/ANo Significant Meetings 
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research8/29/11-9/2/11N/AN/AN/ANo Significant Meetings 
Meghan Scott, Acting Associate Commissioner for External Affairs8/29/11-9/2/11N/AN/AN/ANo Significant Meetings 
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health8/29/11-9/2/11N/AN/AN/ANo Significant Meetings 
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research8/28/11-8/31/11 Paris, France N/A N/A SOT/EUROTOX Debate Scientific Session, 47th Congress of the European Societies of Toxicology (EUROTOX) 
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research9/1/11-9/2/11Paris, FranceN/AN/APresentation on Regulatory Science at the Institute of Pharmacology and Toxicology, Université Paris Descartes
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods8/29/11-9/2/11N/AN/AN/A No Significant Meetings
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs8/29/11-9/2/11N/A N/A No Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research9/1/11Arlington, VASara Goldkind, Badrul ChowdhuryN/AAmerican College of Rheumatology- Clinical Trials